adamantane has been researched along with fluorouracil in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mittelman, A | 1 |
| Chen, MB; Li-Wei, W; Ning, L; Peng, X; Qi, L; Tie-Ning, Z; Xun, C; Zhi-Xiao, C | 1 |
| Abdelhamid, AO; Ali, AG; Mohamed, MF; Mohamed, MS | 1 |
| Amin, S; Jaiswal, AS; Law, BK; Narayan, S; Ramisetti, S; Sharma, AK; Singh, P; Singh-Pillay, A | 1 |
4 other study(ies) available for adamantane and fluorouracil
| Article | Year |
|---|---|
New agents for prostatic carcinoma.
Topics: Adamantane; Alkylating Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Estramustine; Fluorouracil; Humans; Male; Prostatic Neoplasms | 1981 |
Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo.
Topics: Adamantane; Animals; Antineoplastic Agents; Cell Proliferation; Cisplatin; Colorectal Neoplasms; Female; Fluorouracil; HCT116 Cells; HT29 Cells; Humans; Male; MAP Kinase Signaling System; Mice, Nude; Middle Aged; Phosphotransferases (Alcohol Group Acceptor); Pyridines; Xenograft Model Antitumor Assays | 2015 |
A novel adamantane thiadiazole derivative induces mitochondria-mediated apoptosis in lung carcinoma cell line.
Topics: Adamantane; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Membrane; Fluorouracil; Humans; Molecular Docking Simulation; Protein Domains; Proto-Oncogene Proteins c-bcl-2; S Phase Cell Cycle Checkpoints; Thiadiazoles; Tumor Suppressor Protein p53; X-Linked Inhibitor of Apoptosis Protein | 2017 |
ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.
Topics: Adamantane; Antineoplastic Agents; Aza Compounds; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorouracil; HCT116 Cells; HT29 Cells; Humans; Molecular Structure; Oxaliplatin; Stem Cells; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |